What Is Semaglutide?
A long-acting GLP-1 receptor agonist: a 31-residue analog of human GLP-1 (~94% sequence homology) carrying a C18 fatty diacid chain via a linker that drives reversible albumin binding for extended circulation.
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
-1-01KYMQPHK2ZB3W93N3JDBKPHQ6.png&w=640&q=75&dpl=dpl_5xZ6YDhyDczc8FuLwNrZMtzHmvcx)
Metabolic Peptide
A long-acting GLP-1 receptor agonist: a 31-residue analog of human GLP-1 (~94% sequence homology) carrying a C18 fatty diacid chain via a linker that drives reversible albumin binding for extended circulation. Premium Research Peptide.
Technical specifications
A long-acting GLP-1 receptor agonist: a 31-residue analog of human GLP-1 (~94% sequence homology) carrying a C18 fatty diacid chain via a linker that drives reversible albumin binding for extended circulation.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Metabolic pathway research compounds